<DOC>
	<DOCNO>NCT00140036</DOCNO>
	<brief_summary>This protocol describe procedure collection blood sample intent determine genetic contribution safety efficacy CPT/FU/LV .</brief_summary>
	<brief_title>Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin ( CPT-11/FU/LV ) .</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Participation study employ treatment irinotecan sign informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>